Literature DB >> 21973277

Self-reported symptoms in patients on antiepileptic drugs in monotherapy.

U C Wieshmann1, G M Tan, G Baker.   

Abstract

OBJECTIVE: To ascertain the frequency of self-reported symptoms in patients taking antiepileptic drugs (AED).
METHODS: We included patients on carbamazepine (CBZ) n = 36, valproate (VPA) n = 21, levetiracetam (LEV) n = 12, phenytoin (PHT) n = 11, lamotrigine (LTG) n = 20, patients not taking anticonvulsive drugs n = 19, and healthy control subjects (CTRL) n = 41 to complete the Liverpool Adverse Event Profile (LAEP).
RESULTS: The mean LAEP scores were CBZ/PHT/LEV/VPA/LTG/noAED/CTRL = 44.97/42.00/41.00/40.33/32.42/42.00/30.80. LEV scored overall in the same range as the older AED but had a different adverse effect profile with self-reported anger (33%) and shaky hands (42%) particularly frequent. Patients with depression or uncontrolled epilepsy had significantly higher LAEP scores than patients without depression or uncontrolled epilepsy.
CONCLUSION: Our unblinded observational study of self-reported symptoms suggested LTG was overall the drug with the least self-reported symptoms. Larger studies are needed to determine whether this was a truly significant difference. LEV had a different side effect profile to older AED. Confounding factors were depression and uncontrolled epilepsy. This observation should be further tested with randomized studies.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21973277     DOI: 10.1111/j.1600-0404.2011.01488.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  5 in total

Review 1.  Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review.

Authors:  Martin J Brodie; Frank Besag; Alan B Ettinger; Marco Mula; Gabriella Gobbi; Stefano Comai; Albert P Aldenkamp; Bernhard J Steinhoff
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

2.  The Efficacy of Leviteracetam versus Carbamazepine for Epilepsy: A Meta-Analysis.

Authors:  Zhaoxia Li; Zhuanglei Gao; Chengjuan Jin; Qinghui Guo; Lihua Wang; Shandan Wang; Xue Zhang; Yayun Wang
Journal:  Iran J Public Health       Date:  2014-12       Impact factor: 1.429

3.  Psychiatric and behavioral adverse events in randomized clinical studies of the noncompetitive AMPA receptor antagonist perampanel.

Authors:  Alan B Ettinger; Antonia LoPresti; Haichen Yang; Betsy Williams; Sharon Zhou; Randi Fain; Antonio Laurenza
Journal:  Epilepsia       Date:  2015-07-03       Impact factor: 5.864

4.  Self-reported feelings of anger and aggression towards others in patients on levetiracetam: data from the UK antiepileptic drug register.

Authors:  Udo Carl Wieshmann; Gus A Baker
Journal:  BMJ Open       Date:  2013-03-19       Impact factor: 2.692

5.  Association between Adverse Effects and Parental Beliefs about Antiepileptic Medicines.

Authors:  Violeta Ilić; Dragana Bogićević; Branislava Miljković; Sandra Vezmar-Kovačević
Journal:  Medicina (Kaunas)       Date:  2018-08-28       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.